News

After a final follow-up visit at Saint Luke's North Hospital, 84-year-old Carl Linck and his grandson are entering the holiday season with an extra sense of gratitude.

It was a warm, late summer day in Kansas City when Carl Linck, 84, was cruising down Interstate 29 with his 15-year-old grandson riding shotgun.

In 2017, Charles Koslowsky, 70, learned he had a rare form of pancreatic cancer. It had metastasized to his liver.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Dr. Sanjaya Gupta spoke to KSHB about pulsed field ablation, as well as the second Saint Luke's patient to undergo this innovative new procedure to treat AFib.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

MedCity News talked to Dr. Sanjaya Gupta, cardiologist at Saint Luke's Mid America Heart Institue, about how the new virtual program to help patients with atrial fibrillation came to be.